Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Susan K. Quella"'
Autor:
Susan K. Quella, Sandya Pruthi, Jeff A. Sloan, Debra L. Barton, Charles L. Loprinzi, Paul J. Novotny
Publikováno v:
Journal of Pain and Symptom Management. 24:603-607
To evaluate the efficacy of a long-acting preparation of medroxyprogesterone acetate for hot flash management, 3 men receiving androgen ablation therapy for prostate cancer and 15 women with a history of breast cancer were treated as part of clinical
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::64298a25020a313168ce80bb14f177e8
https://doi.org/10.1016/s0885-3924(02)00525-0
https://doi.org/10.1016/s0885-3924(02)00525-0
Publikováno v:
Clinical Breast Cancer. 1:52-56
Hot flashes are the most prominent side effect of tamoxifen, the most frequently prescribed antitumor agent in the world. Little detailed information is available to predict who will develop hot flashes on tamoxifen, to describe the natural history o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::414c428f52dbe7ad2054d5802f830383
https://doi.org/10.3816/cbc.2000.n.004
https://doi.org/10.3816/cbc.2000.n.004
Autor:
Rafael Fonseca, Edith A. Perez, Charles L. Loprinzi, Paul J. Novotny, Susan K. Quella, Teresa A. Rummans, Thomas M. Pisansky, Daniel A. Dumesic, Katherine M. Zahasky, Jeff A. Sloan
Publikováno v:
Journal of Clinical Oncology. 16:2377-2381
PURPOSE Hot flashes can be a prominent clinical problem for breast cancer survivors and men who undergo androgen-deprivation therapy. Anecdotal information suggested a low dose of a relatively new antidepressant, venlafaxine, could abrogate this clin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::801c4e991cbec6b8970898f8be26ea42
https://doi.org/10.1200/jco.1998.16.7.2377
https://doi.org/10.1200/jco.1998.16.7.2377
Autor:
R N Nancy Pierson, R N Gwen Finck, Susan K. Quella, Charles L. Loprinzi, Jeff A. Sloan, Thomas M. Pisansky, Nancy L. Vaught, Tammy Fischer, L R N Wanda DeKrey
Publikováno v:
Cancer. 82:1784-1788
BACKGROUND Hot flashes are often a troublesome symptom in breast carcinoma survivors and men with prostate carcinoma who have undergone androgen deprivation therapy. A previous clinical study demonstrated that, on a short term basis, low dose megestr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cbb3ff1af523087869e2470a93c63f16
https://doi.org/10.1002/(sici)1097-0142(19980501)82:9<1789::aid-cncr27>3.0.co
https://doi.org/10.1002/(sici)1097-0142(19980501)82:9<1789::aid-cncr27>3.0.co
Autor:
Charles L. Loprinzi, James R. Egner, Michael H. Veeder, Paul J. Novotny, Susan K. Quella, Debra K. Swan, Debra L. Barton, Jeff A. Sloan, Nancy L. Vaught, Philip J. Stella, Pat Fidler
Publikováno v:
Journal of Clinical Oncology. 16:495-500
PURPOSE Hot flashes represent a substantial clinical problem for some breast cancer survivors. Although estrogen or progesterone preparations can alleviate these symptoms in many patients, concern remains regarding the use of hormonal preparations in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::66a38f1ef36a781e85aaadfdd8cb6f33
https://doi.org/10.1200/jco.1998.16.2.495
https://doi.org/10.1200/jco.1998.16.2.495
Autor:
Paul J. Novotny, Susan K. Quella, John C. Michalak, Paul L. Schaefer, D. F. White, Jeff A. Sloan, Charles L. Loprinzi, Preston D. Steen, James B. Gerstner, A K Hatfield, Chirantan Ghosh, John K. Camoriano
Publikováno v:
Journal of Clinical Oncology. 15:1235-1238
PURPOSE Stomatitis is a major dose-limiting toxicity of bolus fluorouracil (5FU)-based chemotherapy regimens, despite the use of oral cryotherapy. Pursuant to preliminary data that suggested a sucralfate oral solution could alleviate chemotherapy-ind
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6a065c1eafef76daff3358c5576425d0
https://doi.org/10.1200/jco.1997.15.3.1235
https://doi.org/10.1200/jco.1997.15.3.1235
Autor:
Charles L. Loprinzi, Claudia Johnson, Robert A. Nelimark, John C. Michalak, Joseph E. Oesterling, Tammy Fischer, Walter W. Bate, Judith R. O'Fallon, Susan K. Quella, Raylene M. Rospond, Alan K. Hatfield, Ann Marie Dose, Nancy E. Klatt
Publikováno v:
New England Journal of Medicine. 331:347-352
Vasomotor hot flashes are a common symptom in women during menopause and in men who have undergone androgen-deprivation therapy for prostate cancer. Although treatment with estrogens in women and androgens in men can attenuate these symptoms, these h
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::21b833a995122752fdc548d1c124a01f
https://doi.org/10.1056/nejm199408113310602
https://doi.org/10.1056/nejm199408113310602
Autor:
Susan K. Quella
Publikováno v:
Novel Anticancer Agents ISBN: 9780120885619
Publisher Summary This chapter outlines the patient accrual to clinical trials. Techniques for accruing patients are as diverse as the research professionals themselves. Due to the complex nature of modern health care, no single individual can accrue
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::34cd5065e5d7ed619751ccd79b6b1b75
https://doi.org/10.1016/b978-012088561-9/50019-3
https://doi.org/10.1016/b978-012088561-9/50019-3
Autor:
Ann Marie Dose, Kay M. B. Thiemann, Susan K. Quella, Shauna Hillman, Jane Harper Chelf, Amy M. B. Deshler
Publikováno v:
Oncology nursing forum. 29(5)
PURPOSE/OBJECTIVES To identify content items for an inclusive education curriculum for adult patients with cancer, as well as describe their learning and support preferences, determine the level of information provided to them, and assess the patient
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1b51f3d35bd6d8c58e690ae735163f90
https://pubmed.ncbi.nlm.nih.gov/12058161
https://pubmed.ncbi.nlm.nih.gov/12058161
Autor:
Edith A. Perez, Jeff A. Sloan, Paul J. Novotny, Thomas M. Pisansky, Patrick A. Burch, Stanley J. Antolak, Charles L. Loprinzi, Susan K. Quella
Publikováno v:
The Journal of urology. 162(1)
Hot flashes may be a significant clinical problem in men undergoing androgen deprivation therapy with gonadotropin releasing hormone analogues, oral antiandrogens and/or surgical bilateral orchiectomy. Anecdotal information suggests that a low dose o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6031d1a923c6a463525fac2cd649b29f
https://pubmed.ncbi.nlm.nih.gov/10379749
https://pubmed.ncbi.nlm.nih.gov/10379749